Wall Street Sees an 18% Upside to Elevance Health (ELV)

Elevance Health, Inc. (NYSE:ELV) is one of the best stocks to buy according to Seth Klarman. As of December 12, the average price target for ELV suggests an upside of 10%; however, the Street high indicates an upside of 18%. According to Klarman’s 13F portfolio, the billionaire holds a $426 million stake in Elevance Health as of Q3 2025. On November 26, TD Cowen analyst Ryan Langston reiterated a Buy recommendation on Elevance Health and raised the target price from $380 to $400. The firm named the compan ...